Sqz Biotechnologies Co Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Sqz Biotechnologies current Real Value cannot be determined due to lack of data. The regular price of Sqz Biotechnologies is $0.0. Our model measures the value of Sqz Biotechnologies from inspecting the company fundamentals such as Shares Owned By Insiders of 3.12 %, return on equity of -1.05, and Current Valuation of (6.5 M) as well as reviewing its technical indicators and probability of bankruptcy.
Sqz Biotechnologies Total Value Analysis
Sqz Biotechnologies Co is at this time projected to have company total value of (6.5 M) with market capitalization of 12.83 M, debt of 27.47 M, and cash on hands of 63.71 M. The negative valuation of Sqz Biotechnologies may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Sqz Biotechnologies fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(6.5 M) | 12.83 M | 27.47 M | 63.71 M |
Sqz Biotechnologies Investor Information
About 67.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.5. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sqz Biotechnologies recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 7th of July 2023. Based on the key indicators related to Sqz Biotechnologies' liquidity, profitability, solvency, and operating efficiency, Sqz Biotechnologies Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Sqz Biotechnologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sqz Biotechnologies has an asset utilization ratio of 21.05 percent. This suggests that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that Sqz Biotechnologies Co is more efficient with each dollar of assets it utilizes for everyday operations.Sqz Biotechnologies Ownership Allocation
Sqz Biotechnologies shows a total of 29.49 Million outstanding shares. Over half of Sqz Biotechnologies' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sqz Biotechnologies Profitability Analysis
The company reported the last year's revenue of 21.03 M. Reported Net Loss for the year was (79.46 M) with loss before taxes, overhead, and interest of (43.05 M).Sqz Biotechnologies Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 28.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |